Wave Life Sciences
Latest round
- Series B
Last raised
- Aug 2015
Total raised
- $84M
Investors
- 9
About Wave Life Sciences
a. Wave Life Sciences operates as a clinical-stage biotechnology company that focuses on designing, developing, and commercializing ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. In December 2023, Wave Life Sciences Ltd. As of May 2024, Paul Bolno is the CEO of the company. Wave Life Sciences leverages its proprietary PRISM platform to develop RNA medicines that treat a wide range of disorders. PRISM combines various modalities, innovative chemistry, and human genetics insights to create oligonucleotides designed to engage messenger RNA (mRNA) and address diseases by repairing, restoring, or reducing proteins. The platform allows for the modulation of transcriptional diversity, targeting different cell types, and utilizing established manufacturing and regulatory processes. The company’s key programs include WVE-006 for Alpha-1 antitrypsin deficiency, WVE-N531 for Duchenne muscular dystrophy, and WVE-003 for Huntington's disease.
Who invested in Wave Life Sciences
9 investors across 2 rounds
See all investors in Wave Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wave Life Sciences
Who invested in Wave Life Sciences?
Wave Life Sciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wave Life Sciences raised?
Wave Life Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Wave Life Sciences last raise money?
Wave Life Sciences's most recent round on record is a Series B, in Aug 2015.
What does Wave Life Sciences do?
Wave Life Sciences is a biotechnology company.
Where is Wave Life Sciences headquartered?
Wave Life Sciences is headquartered in Cambridge, US.
Which VCs invest in companies like Wave Life Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Wave Life Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Wave Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.